Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Swiss Tropical and Public Health Institute, Basel, Switzerland.
PLoS Negl Trop Dis. 2021 May 25;15(5):e0009444. doi: 10.1371/journal.pntd.0009444. eCollection 2021 May.
World Health Organization (WHO) guidelines for measuring global progress in schistosomiasis control classify individuals with Schistosoma spp. infections based on the concentration of excreted eggs. We assessed the associations between WHO infection intensity categories and morbidity prevalence for selected S. haematobium and S. mansoni morbidities in school-age children.
A total of 22,488 children aged 6-15 years from monitoring and evaluation cohorts in Burkina Faso, Mali, Niger, Uganda, Tanzania, and Zambia from 2003-2008 were analyzed using Bayesian logistic regression. Models were utilized to evaluate associations between intensity categories and the prevalence of any urinary bladder lesion, any upper urinary tract lesion, microhematuria, and pain while urinating (for S. haematobium) and irregular hepatic ultrasound image pattern (C-F), enlarged portal vein, laboratory-confirmed diarrhea, and self-reported diarrhea (for S. mansoni) across participants with infection and morbidity data.
S. haematobium infection intensity categories possessed consistent morbidity prevalence across surveys for multiple morbidities and participants with light infections had elevated morbidity levels, compared to negative participants. Conversely, S. mansoni infection intensity categories lacked association with prevalence of the morbidity measures assessed.
CONCLUSIONS/SIGNIFICANCE: Current status infection intensity categories for S. haematobium were associated with morbidity levels in school-age children, suggesting urogenital schistosomiasis morbidity can be predicted by an individual's intensity category. Conversely, S. mansoni infection intensity categories were not consistently indicative of childhood morbidity at baseline or during the first two years of a preventive chemotherapy control program.
世界卫生组织(WHO)衡量血吸虫病控制全球进展的指南根据排泄卵的浓度对曼氏血吸虫和埃及血吸虫感染个体进行分类。我们评估了 WHO 感染强度类别与选定的曼氏血吸虫和埃及血吸虫小学生发病的发病率之间的关联。
2003-2008 年,来自布基纳法索、马里、尼日尔、乌干达、坦桑尼亚和赞比亚监测和评估队列的 22488 名 6-15 岁儿童使用贝叶斯逻辑回归进行了分析。模型用于评估感染强度类别与任何膀胱病变、任何上尿路病变、镜下血尿和排尿时疼痛(用于曼氏血吸虫)以及不规则肝超声图像模式(C-F)、门静脉扩张、实验室确认的腹泻和自我报告的腹泻(用于曼氏血吸虫)在感染和发病数据的参与者之间的关联。
曼氏血吸虫感染强度类别在多次发病和轻度感染者中,与多个发病的发病率具有一致的相关性,与阴性参与者相比,轻度感染者的发病率水平升高。相反,曼氏血吸虫感染强度类别与评估的发病测量的患病率缺乏关联。
结论/意义:当前的曼氏血吸虫现症感染强度类别与学龄儿童的发病水平相关,这表明泌尿生殖道血吸虫病的发病可以通过个体的强度类别来预测。相反,曼氏血吸虫感染强度类别在基线或在预防化疗控制计划的头两年内并不始终表明儿童发病。